National Bank of Canada
FUSN

National Bank of Canada’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

National Bank of Canada’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500
Closed -$1.19K – 2927
2023
Q3 		$1.19K Buy
+500
New +$1.6K ﹤0.01% 2566

Other funds holding FUSN

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

National Bank of Canada's FUSN Position: Q4 2023 in Review

National Bank of Canada sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q4 2023, closing a stake of 500 shares — an estimated $1.19K sold.

National Bank of Canada first reported a position in FUSN in Q3 2023 and held it in 1 quarter. The position peaked at $1.19K in Q3 2023. 77 funds tracked by Wall St. Rank hold FUSN as of Q4 2023.

  • National Bank of Canada reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q4 2023 after selling out during the quarter.
  • National Bank of Canada sold 500 Fusion Pharmaceuticals Inc. Common Shares shares in Q4 2023, an estimated $1.19K.
  • National Bank of Canada first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2023 and held it in 1 quarter.
  • National Bank of Canada's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.19K in Q3 2023.
  • 77 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q4 2023.

Based on National Bank of Canada's 13F filing for Q4 2023, filed 6 Feb 2024.